Published in Exp Ther Med on April 28, 2017
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest (2002) 9.50
Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab (2004) 3.75
A microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int (1996) 2.98
1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem (2007) 2.61
Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int (2008) 2.59
Femoral vein ligation increases bone mass in the hindlimb suspended rat. Bone (1999) 1.95
Relationship between bone mineral density and angiotensin converting enzyme polymorphism in hypertensive postmenopausal women. Am J Hypertens (2003) 1.52
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens (2006) 1.48
Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta (2010) 1.46
Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J (2008) 1.42
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 1.36
The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int (2006) 1.24
The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes Rev (2011) 1.23
A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM (2005) 1.21
Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res (2011) 1.20
Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone (2005) 1.14
Three-dimensional morphometry of the L6 vertebra in the ovariectomized rat model of osteoporosis: biomechanical implications. J Bone Miner Res (2000) 1.11
Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose. Regul Toxicol Pharmacol (2004) 1.07
Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res (2009) 1.07
Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation - role of a local renin-angiotensin system. Br J Pharmacol (2010) 1.06
Angiotensin II type 2 receptor blockade increases bone mass. J Biol Chem (2008) 1.03
Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol (2003) 0.98
Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol (1997) 0.98
Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells. J Endocrinol (1998) 0.93
Fluid shifts due to microgravity and their effects on bone: a review of current knowledge. Ann Biomed Eng (2005) 0.92
Glucocorticoids activate the local renin-angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis. Endocrine (2014) 0.90
Effect of angiotensin II type 1 receptor blocker on osteoporotic rat femurs. Pharmacol Rep (2012) 0.86
Management of glucocorticoid-induced osteoporosis. Calcif Tissue Int (2012) 0.84
Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts. J Bone Miner Metab (2010) 0.83
Angiotensin-I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density. J Clin Endocrinol Metab (2001) 0.82
Jacques Benoit lecture: the neuroendocrine view of the angiotensin and apelin systems. J Neuroendocrinol (2008) 0.82
Effect of Qing'e formula on circulating sclerostin levels in patients with postmenopausal osteoporosis. J Huazhong Univ Sci Technolog Med Sci (2015) 0.80
Assessment of the Impact of Zoledronic Acid on Ovariectomized Osteoporosis Model Using Micro-CT Scanning. PLoS One (2015) 0.79
Renin inhibition improves ovariectomy-induced osteoporosis of lumbar vertebra in mice. Biol Pharm Bull (2014) 0.78
Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients. Osteoporos Int (2014) 0.77
Effect of Qing'e formula on the in vitro differentiation of bone marrow-derived mesenchymal stem cells from proximal femurs of postmenopausal osteoporotic mice. BMC Complement Altern Med (2015) 0.76